Clinical Trial Update: SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SBRT in combination with a PD-1 inhibitor and chemotherapy for oligometastatic nasopharyngeal carcinoma; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING